Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma
- PMID: 12648583
- DOI: 10.1016/s0090-8258(02)00150-6
Endocrine tumors of the uterine cervix: incidence, demographics, and survival with comparison to squamous cell carcinoma
Abstract
Objective: The aim was to describe the epidemiology of endocrine tumors of the cervix in comparison with invasive squamous cell carcinomas using population-based data reported to the Surveillance, Epidemiology and End-Results (SEER) program.
Methods: Retrospective analysis of actively followed cases reported to SEER from 1973 to 1998. Incidence, demographic characteristics, and survival were compared for endocrine and squamous tumors.
Results: There were 239 cases of endocrine tumors and 18,458 cases of invasive squamous cell carcinoma of the cervix included in the study. Mean age at diagnosis was 49 years for endocrine tumors versus 52 years for squamous cell carcinoma (P < 0.01). Endocrine tumors were more likely to present at a later FIGO stage (P < 0.01), and to have lymph node involvement at diagnosis (57 vs 18%, P < 0.01) compared to squamous cell carcinoma. Observed median survival for women with endocrine tumors was 22 months versus 10 years for women with squamous cell carcinoma. Age and FIGO stage-adjusted hazards of death were 1.84 times greater for endocrine tumors than for squamous cell carcinoma (95% CI 1.52-2.23). At all stages of disease, survival was worse for women with endocrine tumors compared to women with squamous cell carcinomas.
Conclusions: Endocrine tumors of the cervix are extremely aggressive and survival is poor regardless of stage at diagnosis.
Similar articles
-
Natural history and outcome of neuroendocrine carcinoma of the cervix.Gynecol Oncol. 2016 May;141(2):247-254. doi: 10.1016/j.ygyno.2016.02.008. Epub 2016 Feb 9. Gynecol Oncol. 2016. PMID: 26873865 Free PMC article.
-
The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study.Gynecol Oncol. 2000 Aug;78(2):97-105. doi: 10.1006/gyno.2000.5826. Gynecol Oncol. 2000. PMID: 10926787
-
Association of tumor differentiation grade and survival of women with squamous cell carcinoma of the uterine cervix.J Gynecol Oncol. 2018 Nov;29(6):e91. doi: 10.3802/jgo.2018.29.e91. J Gynecol Oncol. 2018. PMID: 30207099 Free PMC article.
-
Survival of women with microinvasive adenocarcinoma of the cervix is not improved by radical surgery.Am J Obstet Gynecol. 2017 Sep;217(3):332.e1-332.e6. doi: 10.1016/j.ajog.2017.05.021. Epub 2017 May 15. Am J Obstet Gynecol. 2017. PMID: 28522318
-
Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma.Cancer. 2003 May 1;97(9):2196-202. doi: 10.1002/cncr.11371. Cancer. 2003. PMID: 12712471 Review.
Cited by
-
Advancements in the Understanding of Small-Cell Neuroendocrine Cervical Cancer: Where We Stand and What Lies Ahead.J Pers Med. 2024 Apr 27;14(5):462. doi: 10.3390/jpm14050462. J Pers Med. 2024. PMID: 38793044 Free PMC article. Review.
-
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix.Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2321898121. doi: 10.1073/pnas.2321898121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625939
-
Small Cell Cervical Carcinoma in Pregnancy: Therapeutic Options for an Aggressive Cancer Diagnosis.AJP Rep. 2024 Jan 23;14(1):e22-e25. doi: 10.1055/s-0043-1777998. eCollection 2024 Jan. AJP Rep. 2024. PMID: 38269128 Free PMC article.
-
Competing risk nomogram and risk classification system for evaluating overall and cancer-specific survival in neuroendocrine carcinoma of the cervix: a population-based retrospective study.J Endocrinol Invest. 2024 Jun;47(6):1545-1557. doi: 10.1007/s40618-023-02261-7. Epub 2024 Jan 3. J Endocrinol Invest. 2024. PMID: 38170396 Free PMC article.
-
Extrapulmonary Neuroendocrine Carcinomas: Current Management and Future Perspectives.J Clin Med. 2023 Dec 15;12(24):7715. doi: 10.3390/jcm12247715. J Clin Med. 2023. PMID: 38137784 Free PMC article. Review.